Effects of urease inhibition in hyperammonemia: clinical and experimental studies with acetohydroxamic acid.
D000368:Aged; D000641:Ammonia / Q000097:blood*; D000818:Animals; D001663:Bilirubin / Q000097:blood; D006502:Budd-Chiari Syndrome / Q000188:drug therapy; D004285:Dogs; D005215:Fasting; D005260:Female; D006501:Hepatic Encephalopathy / Q000188:drug therapy; D006505:Hepatitis / Q000188:drug therapy; D006801:Humans; D006877:Hydroxamic Acids / Q000008:administration & dosage* / Q000009:adverse effects; D008103:Liver Cirrhosis / Q000188:drug therapy; D008107:Liver Diseases / Q000188:drug therapy; D008297:Male; D008659:Metabolic Diseases / Q000188:drug therapy*; D008875:Middle Aged; D009336:Necrosis; D009355:Neomycin; D011167:Portacaval Shunt, Surgical; D012709:Serum Albumin; D014508:Urea / Q000097:blood; D014510:Urease / Q000037:antagonists & inhibitors
D006877:Hydroxamic Acids; D012709:Serum Albumin; D000641:Ammonia; D014508:Urea; D014510:Urease; D009355:Neomycin; D001663:Bilirubin